Urology Cancer Center & GU Research Network — Omaha, Nebraska

Urology Cancer Center & GU Research Network is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Urology Cancer Center & GU Research Network has participated in 6 clinical trials.

Therapeutic areas: Metastatic Prostate Cancer, Prostate Cancer, Bladder Cancer.

Sponsors: Hoffmann-La Roche, Genentech, Inc., Dendreon.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Urology Cancer Center & GU Research Network?

Urology Cancer Center & GU Research Network has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Urology Cancer Center & GU Research Network conducted?

Urology Cancer Center & GU Research Network has 6 clinical trials on record. Their work covers Metastatic Prostate Cancer, Prostate Cancer, Bladder Cancer.

Is Urology Cancer Center & GU Research Network accredited by Crixeo Health?

Urology Cancer Center & GU Research Network has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Urology Cancer Center & GU Research Network?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.